[Parosteal sarcoma of the radius in the course of etretinate therapy].
A parosteal osteosarcoma of the right radius has developed in a patient treated for a long time by etretinate (total dose: 73 g). If brachial ossifications have been reported to etretinate in 2 cases, they were benign tumours; so coincidence is possible in our case. Nevertheless, a relation between the tumour and the treatment cannot be excluded and justify the report of this observation.
Vilon
P
P
Service de Rhumatologie, Hôpital Saint Jacques, Nantes.
Fiche
M
M
Maugars
Y
Y
Ducloux
J M
JM
Carlier
N
N
Poirier
P
P
Forest
M
M
Prost
A
A
D001859:Bone Neoplasms / Q000139:chemically induced* / Q000601:surgery; D005050:Etretinate / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012516:Osteosarcoma / Q000139:chemically induced* / Q000601:surgery; D011884:Radius / Q000601:surgery
D005050:Etretinate
Sarcome parostéal du radius apparu lors d'un traitement par étrétinate.